Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1958 1
1959 3
1960 1
1961 2
1965 2
1966 1
1967 1
1968 1
1969 1
1970 1
1971 1
1972 4
1973 2
1974 4
1975 4
1976 9
1977 3
1978 15
1979 13
1980 19
1981 11
1982 15
1983 13
1984 18
1985 16
1986 15
1987 13
1988 14
1989 14
1990 13
1991 10
1992 12
1993 13
1994 14
1995 18
1996 15
1997 14
1998 12
1999 12
2000 12
2001 11
2002 16
2003 11
2004 14
2005 17
2006 15
2007 8
2008 31
2009 20
2010 25
2011 19
2012 22
2013 25
2014 30
2015 28
2016 30
2017 33
2018 35
2019 45
2020 36
2021 27
2022 27
2023 30
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

870 results

Results by year

Filters applied: . Clear all
Page 1
T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Horwitz SM, Ansell S, Ai WZ, Barnes J, Barta SK, Brammer J, Clemens MW, Dogan A, Foss F, Ghione P, Goodman AM, Guitart J, Halwani A, Haverkos BM, Hoppe RT, Jacobsen E, Jagadeesh D, Jones A, Kallam A, Kim YH, Kumar K, Mehta-Shah N, Olsen EA, Rajguru SA, Rozati S, Said J, Shaver A, Shea L, Shinohara MM, Sokol L, Torres-Cabala C, Wilcox R, Wu P, Zain J, Dwyer M, Sundar H. Horwitz SM, et al. Among authors: clemens mw. J Natl Compr Canc Netw. 2022 Mar;20(3):285-308. doi: 10.6004/jnccn.2022.0015. J Natl Compr Canc Netw. 2022. PMID: 35276674
NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020.
Mehta-Shah N, Horwitz SM, Ansell S, Ai WZ, Barnes J, Barta SK, Clemens MW, Dogan A, Fisher K, Goodman AM, Goyal G, Guitart J, Halwani A, Haverkos BM, Hoppe RT, Jacobsen E, Jagadeesh D, Lunning MA, Mehta A, Olsen EA, Pro B, Rajguru SA, Shanbhag S, Shaver A, Shustov A, Sokol L, Torka P, Torres-Cabala C, Wilcox R, William BM, Zain J, Dwyer MA, Sundar H, Kim YH. Mehta-Shah N, et al. Among authors: clemens mw. J Natl Compr Canc Netw. 2020 May;18(5):522-536. doi: 10.6004/jnccn.2020.0022. J Natl Compr Canc Netw. 2020. PMID: 32380458
Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial.
Al-Batran SE, Hofheinz RD, Pauligk C, Kopp HG, Haag GM, Luley KB, Meiler J, Homann N, Lorenzen S, Schmalenberg H, Probst S, Koenigsmann M, Egger M, Prasnikar N, Caca K, Trojan J, Martens UM, Block A, Fischbach W, Mahlberg R, Clemens M, Illerhaus G, Zirlik K, Behringer DM, Schmiegel W, Pohl M, Heike M, Ronellenfitsch U, Schuler M, Bechstein WO, Königsrainer A, Gaiser T, Schirmacher P, Hozaeel W, Reichart A, Goetze TO, Sievert M, Jäger E, Mönig S, Tannapfel A. Al-Batran SE, et al. Among authors: clemens m. Lancet Oncol. 2016 Dec;17(12):1697-1708. doi: 10.1016/S1470-2045(16)30531-9. Epub 2016 Oct 22. Lancet Oncol. 2016. PMID: 27776843 Clinical Trial.
West German Study PlanB Trial: Adjuvant Four Cycles of Epirubicin and Cyclophosphamide Plus Docetaxel Versus Six Cycles of Docetaxel and Cyclophosphamide in HER2-Negative Early Breast Cancer.
Nitz U, Gluz O, Clemens M, Malter W, Reimer T, Nuding B, Aktas B, Stefek A, Pollmanns A, Lorenz-Salehi F, Uleer C, Krabisch P, Kuemmel S, Liedtke C, Shak S, Wuerstlein R, Christgen M, Kates RE, Kreipe HH, Harbeck N; West German Study Group PlanB Investigators. Nitz U, et al. Among authors: clemens m. J Clin Oncol. 2019 Apr 1;37(10):799-808. doi: 10.1200/JCO.18.00028. Epub 2019 Feb 20. J Clin Oncol. 2019. PMID: 30785826 Clinical Trial.
Rectal Trauma: Evidence-Based Practices.
Clemens MS, Peace KM, Yi F. Clemens MS, et al. Clin Colon Rectal Surg. 2018 Jan;31(1):17-23. doi: 10.1055/s-0037-1602182. Epub 2017 Dec 19. Clin Colon Rectal Surg. 2018. PMID: 29379403 Free PMC article. Review.
What's New in Shock, December 2018?
Clemens MG. Clemens MG. Shock. 2018 Dec;50(6):613-615. doi: 10.1097/SHK.0000000000001264. Shock. 2018. PMID: 30422930 No abstract available.
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60).
Pfreundschuh M, Schubert J, Ziepert M, Schmits R, Mohren M, Lengfelder E, Reiser M, Nickenig C, Clemens M, Peter N, Bokemeyer C, Eimermacher H, Ho A, Hoffmann M, Mertelsmann R, Trümper L, Balleisen L, Liersch R, Metzner B, Hartmann F, Glass B, Poeschel V, Schmitz N, Ruebe C, Feller AC, Loeffler M; German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL). Pfreundschuh M, et al. Among authors: clemens m. Lancet Oncol. 2008 Feb;9(2):105-16. doi: 10.1016/S1470-2045(08)70002-0. Epub 2008 Jan 15. Lancet Oncol. 2008. PMID: 18226581 Clinical Trial.
Augmentation mastopexy.
Spear SL, Dayan JH, Clemens MW. Spear SL, et al. Among authors: clemens mw. Clin Plast Surg. 2009 Jan;36(1):105-15, vii; discussion 117. doi: 10.1016/j.cps.2008.08.006. Clin Plast Surg. 2009. PMID: 19055965
Ein Investitionsprogramm zur Krisenbewältigung.
Clemens M, Fratzscher M, Michelsen C. Clemens M, et al. Wirtschaftsdienst. 2021;101(3):168-171. doi: 10.1007/s10273-021-2868-7. Epub 2021 Mar 17. Wirtschaftsdienst. 2021. PMID: 33746301 Free PMC article. German. No abstract available.
Interferons and apoptosis.
Clemens MJ. Clemens MJ. J Interferon Cytokine Res. 2003 Jun;23(6):277-92. doi: 10.1089/107999003766628124. J Interferon Cytokine Res. 2003. PMID: 12859854 Review.
870 results